Building on a foundation of expertise in cancer research and medical device development, Verinnogen looks to tackle one of the biggest unmet technological needs in pre-clinical cancer research: quick and accurate estimation of subcutaneous tumour volume. Our hand-held, contact-based 3D profiler could expedite the translation of in vivo cancer research by capturing the entire 3D surface efficiently and accurately, no matter who is performing the measurement, saving time, money, and animals. This, alongside other metrics and components, will positively impact animal welfare and 3R’s considerations, where we firmly believe better welfare equals better science.

Development of therapies is reliant upon dependable, accurate, and repeatable data collection. We aim to maximise the confidence in your data, while streamlining the collection process. Based in Cambridge, UK, in amongst a vibrant cancer research community, we actively seek engagement from our potential users and, together, we can bring tumour volume measurements in to the 21st Century.


Get involved with Advanced Therapies Congress


To speak

Jessica Robinson
+44 208 164 3086



To sponsor or exhibit

Ashlea Foster
+44 208 164 3032